Pang J, Qian LY, Lv P, Che XR. Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure. World J Diabetes 2024; 15(6): 1226-1233 [PMID: 38983818 DOI: 10.4239/wjd.v15.i6.1226]
Corresponding Author of This Article
Xiao-Ru Che, Doctor, Associate Chief Physician, Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People’s Hospital (The Affiliated People’s Hospital), Hangzhou Medical College, No. 158 Shangtang Road, Gongshu District, Hangzhou 310014, Zhejiang Province, China. sananc@163.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Jun 15, 2024; 15(6): 1226-1233 Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
Table 1 Comparison of patients’ general data
Research (n = 65)
Control (n = 60)
t/χ2
P value
95%CI
Sex (male/female)
39/26
40/20
0.5962
0.4400
0.3610 to 1.5580
Average age (yr)
64.66 ± 5.45
66.63 ± 6.15
1.6132
0.1093
-0.3856 to 3.8370
BMI (kg/m2)
22.39 ± 1.75
22.91 ± 1.84
1.6193
0.7079
-0.1081 to 1.1630
Course of diabetes mellitus (yr)
10.58 ± 1.95
10.68 ± 2.74
0.2365
0.8135
-1.1820 to 2.2130
NYHA grading of cardiac function
125.03
< 0.0001
I
0
60
II
19
0
III
25
0
IV
21
0
History of hypertension
30
25
0.2550
0.6136
0.5911 to 2.4360
Smoking history
32
23
1.5041
0.2201
0.7651 to 3.181
Table 2 Neutrophil-lymphocyte ratio and red blood cell distribution width levels in two groups
NLR
RDW
LVEF (%)
Research (n = 65)
5.40 ± 1.79
16.00 ± 1.63
41.85 ± 7.23
Control (n = 60)
2.99 ± 0.98
13.88 ± 1.08
58.07 ± 6.79
t
9.2283
8.4976
12.9016
P value
< 0.0001
< 0.0001
< 0.0001
95%CI
-2.921 to -1.889
-2.619 to -1.629
13.73 to 18.71
Table 3 Comparison of general data in research groups with different cardiac function grades
NYHA classification
n
Male
Age (mean ± SD)
Course of diabetes mellitus
NLR
RDW
LEVF (%)
II
19
8
62.79 ± 4.83
10.77 ± 1.83
3.91 ± 1.64
14.72 ± 1.25
45.82 ± 6.14
III
25
16
65.84 ± 5.81
10.30 ± 1.96
5.55 ± 1.31
15.53 ± 1.04
42.75 ± 5.94
IV
21
15
65.71 ± 6.25
10.75 ± 2.11
6.56 ± 1.48
17.72 ± 0.93
37.20 ± 7.23
F
3.8452
1.8600
0.4070
16.4300
42.7900
9.3240
P value
0.1463
0.1643
0.6674
< 0.0001
< 0.0001
0.0003
Table 4 Diagnostic efficiency of neutrophil-lymphocyte ratio and red blood cell distribution width
AUC
SE
Specificity (%)
Sensitivity (%)
95%CI
NLR
0.864
0.033
90.0
75.4
0.799-0.929
RDW
0.859
0.034
86.7
76.9
0.793-0.925
Joint detection
0.915
0.027
100.0
76.9
0.863-0.968
Table 5 Comparison of neutrophil-lymphocyte ratio and red blood cell distribution width levels in patients with or without cardiac events
n
NLR
RDW
Without cardiac events
46
4.97 ± 1.66
15.70 ± 1.64
With cardiac events
19
6.45 ± .68
16.72 ± 1.42
t
3.2610
2.3540
P value
0.0018
0.0217
Citation: Pang J, Qian LY, Lv P, Che XR. Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure. World J Diabetes 2024; 15(6): 1226-1233